Cytosorbents CorpNASDAQ:CTSONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.7000/ 10
- Ask / Lots0.8181/ 5
- Open / Previous Close0.0000 / 0.7000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CTSO |
|---|---|---|
| 09:32 ET | 160 | 0.7144 |
| 09:43 ET | 711 | 0.7381 |
| 09:45 ET | 5550 | 0.72 |
| 09:48 ET | 3200 | 0.72 |
| 09:50 ET | 700 | 0.738 |
| 09:54 ET | 100 | 0.73 |
| 09:56 ET | 250 | 0.7302 |
| 09:59 ET | 100 | 0.7301 |
| 10:01 ET | 100 | 0.76 |
| 10:06 ET | 100 | 0.73 |
| 10:14 ET | 100 | 0.73 |
| 10:19 ET | 100 | 0.733 |
| 10:26 ET | 500 | 0.7517 |
| 10:28 ET | 100 | 0.733 |
| 10:30 ET | 400 | 0.75 |
| 10:32 ET | 560 | 0.733 |
| 10:35 ET | 100 | 0.733 |
| 10:39 ET | 777 | 0.769465 |
| 10:46 ET | 600 | 0.733 |
| 10:48 ET | 2945 | 0.75 |
| 10:55 ET | 100 | 0.75 |
| 10:57 ET | 200 | 0.73 |
| 11:00 ET | 100 | 0.74 |
| 11:02 ET | 305 | 0.74 |
| 11:04 ET | 100 | 0.74 |
| 11:06 ET | 3100 | 0.7301 |
| 11:08 ET | 100 | 0.7301 |
| 11:18 ET | 100 | 0.735 |
| 11:20 ET | 200 | 0.735 |
| 11:31 ET | 100 | 0.73 |
| 11:40 ET | 1190 | 0.735 |
| 11:44 ET | 2100 | 0.73 |
| 11:45 ET | 1700 | 0.7301 |
| 12:02 ET | 100 | 0.7301 |
| 12:05 ET | 6317 | 0.7485 |
| 12:18 ET | 100 | 0.7301 |
| 12:23 ET | 100 | 0.7466 |
| 12:25 ET | 100 | 0.7301 |
| 12:34 ET | 1700 | 0.7351 |
| 12:45 ET | 100 | 0.735 |
| 01:01 ET | 100 | 0.735 |
| 01:08 ET | 100 | 0.7525 |
| 01:17 ET | 100 | 0.74 |
| 01:33 ET | 200 | 0.7466 |
| 01:35 ET | 200 | 0.7466 |
| 01:37 ET | 300 | 0.75 |
| 01:39 ET | 1544 | 0.75 |
| 01:50 ET | 100 | 0.745 |
| 01:53 ET | 7413 | 0.735 |
| 02:00 ET | 100 | 0.735 |
| 02:08 ET | 1800 | 0.7515 |
| 02:11 ET | 600 | 0.73 |
| 02:18 ET | 544 | 0.749 |
| 02:22 ET | 100 | 0.749 |
| 02:36 ET | 1040 | 0.732 |
| 02:40 ET | 5528 | 0.7349 |
| 02:42 ET | 803 | 0.74 |
| 02:44 ET | 10300 | 0.7304 |
| 02:56 ET | 100 | 0.721 |
| 03:05 ET | 100 | 0.721 |
| 03:12 ET | 100 | 0.7212 |
| 03:14 ET | 1319 | 0.7212 |
| 03:16 ET | 1851 | 0.7194 |
| 03:20 ET | 100 | 0.71 |
| 03:25 ET | 100 | 0.71 |
| 03:34 ET | 100 | 0.71 |
| 03:38 ET | 904 | 0.71 |
| 03:39 ET | 100 | 0.7025 |
| 03:41 ET | 1000 | 0.7283 |
| 03:45 ET | 100 | 0.71 |
| 03:50 ET | 100 | 0.707 |
| 03:52 ET | 1800 | 0.7093 |
| 03:54 ET | 100 | 0.709 |
| 03:56 ET | 300 | 0.709 |
| 03:57 ET | 240 | 0.7063 |
| 03:59 ET | 400 | 0.7 |
Jun 24, 2024
CytoSorbents Announces Regulatory Approval of CytoSorb(R) in Taiwan, from 7:00AM ET on Monday Jun 24, 2024 by Dow Jones
7:00AM ET on Monday Jun 24, 2024 by Dow Jones
Jun 13, 2024
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi(TM) Blood Pump in the European Union, from 7:00AM ET on Thursday Jun 13, 2024 by Dow Jones
7:00AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 5, 2024
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting, from 7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 4, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cytosorbents Corp | 38.0M | -1.2x | --- |
Bionano Genomics Inc | 44.3M | -0.1x | --- |
STRATA Skin Sciences Inc | 10.6M | -0.9x | --- |
LENSAR Inc | 50.7M | -3.9x | --- |
Aamaxan Transport Group Inc | 1.6K | 0.0x | --- |
Dynatronics Corp | 1.2M | -0.2x | --- |
Company Information
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. Its other product candidates under development, including CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent, porous polymer beads, although the polymers used in these devices are physically different.
Contact Information
- Headquarters
- 305 COLLEGE ROAD EASTPRINCETON, NJ, United States 08540
- Phone
- 973-329-8885
- Fax
- ---
Executives
- Independent Non-Executive Chairman of the Board
- Michael Bator
- President, Chief Operating Officer
- Vincent Capponi
- Chief Executive Officer, Director
- Phillip Chan
- Chief Financial Officer
- Kathleen Bloch
- Chief Medical Officer
- Efthymios Deliargyris
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $38.0M |
|---|---|
Revenue (TTM) | $36.7M |
Shares Outstanding | 54.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $-0.59 |
Book Value | $0.43 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 1.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -76.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
